1. Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. (5th August 2019) Authors: Qu, Dongfeng; Weygant, Nathaniel; Yao, Jiannan; Chandrakesan, Parthasarathy; Berry, William L.; May, Randal; Pitts, Kamille; Husain, Sanam; Lightfoot, Stan; Li, Min; Wang, Timothy C.; An, Guangyu; Clendenin, Cynthia; Stanger, Ben Z.; Houchen, Courtney W. Other Names: De Felice Francesca Academic Editor. Journal: Journal of oncology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗